THE LENGHT OF REMISSION AND RATE OF RELAPSE AFTER TOCILIZUMAB WITHDRAWAL IN RHEUMATOID ARTHRITIS PATIENTS

被引:2
|
作者
Aguilar-Lozano, L. [1 ]
Padilla-Ibarra, J. [1 ]
Sandoval-Castro, C. [1 ]
Castillo-Ortiz, J. D. [1 ]
Morales-Torres, J. [2 ]
Hernandez, C. [2 ]
Burgos-Vargas, R. [3 ]
Pacheco-Tena, C. [4 ]
Ramos-Remus, C. [1 ]
机构
[1] Unidad Invest Enfermedades Cron Degenerat, Guadalajara, Jalisco, Mexico
[2] Hosp Aranda de la Parra, Leon, Mexico
[3] Hosp Gen Mexico City, Mexico City, DF, Mexico
[4] UA Chihuahua, Fac Med, Chihuahua, Mexico
关键词
D O I
10.1136/annrheumdis-2012-eular.1732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:69 / 70
页数:2
相关论文
共 50 条
  • [1] Sustained Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Patients with Rheumatoid Arthritis
    Aguilar-Lozano, Luis
    Dionisio Castillo-Ortiz, Jose
    Vargas-Serafin, Cesar
    Morales-Torres, Jorge
    Sanchez-Ortiz, Adriana
    Sandoval-Castro, Carlos
    Padilla-Ibarra, Jorge
    Hernandez-Cuevas, Claudia
    Ramos-Remus, Cesar
    [J]. JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) : 1069 - 1073
  • [2] Clinical Remission and Rate of Relapse After Tocilizumab Withdrawal in Rheumatoid Arthritis Patients.
    Vargas-Serafin, Cesar
    Aguilar-Lozano, Luis
    Padilla-Ibarra, Jorge
    Sandoval-Castro, Carlos
    Dionisio Castillo-Ortiz, Jose
    Morales-Torres, Jorge
    Hernandez, Claudia
    Ramos-Remus, Cesar
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S193 - S193
  • [3] Sustained Remission and Relapse Rate after Non-Conventional DMARD Withdrawal in Patients with Rheumatoid Arthritis
    Ramirez-Gomez, Andrea
    Barajas-Ochoa, Aldo
    Juan Castaneda-Sanchez, Jose
    Dionisio Castillo-Ortiz, Jose
    Sanchez-Gonzalez, Jorge M.
    Ramos-Remus, Cesar
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] SUSTAINED REMISSION AND RATE OF RELAPSE AFTER WITHDRAWAL OF BIOLOGIC OR NON-CONVENTIONAL DMARD IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA)
    Castillo-Ortiz, J. D.
    Castaneda-Sanchez, J. J.
    Ramirez-Gomez, A.
    Sanchez-Gonzalez, J. M.
    Ramos-Remus, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1039 - 1039
  • [5] DISCONTINUATION OF TOCILIZUMAB AFTER ATTAINING REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Nampei, A.
    Nagayama, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 877 - 877
  • [6] Remission of lymphoma after drug withdrawal in rheumatoid arthritis
    Lim, IGS
    Bertouch, JV
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (09) : 500 - 501
  • [7] Remission of Rheumatoid Arthritis and Primary Biliary Cholangitis After Treatment With Tocilizumab
    Azevedo, Soraia
    Sousa-Neves, Joana
    Rodrigues, Joana Ramos
    Peixoto, Daniela
    Tavares-Costa, Jose
    Teixeira, Filipa
    [J]. REUMATOLOGIA CLINICA, 2021, 17 (06): : 364 - 365
  • [8] EXPERIENCE OF SPACING AND WITHDRAWAL OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION: IDENTIFICATION OF RELAPSE PREDICTIVE FACTORS
    Desouches, S.
    Avenel, G.
    Kozyreff, M.
    Nicolau, J.
    Pouplin, S.
    Daragon, A.
    Lequerre, T.
    Vittecoq, O.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 470 - 470
  • [9] Tocilizumab or abatacept spacing in rheumatoid arthritis in remission
    不详
    [J]. LANCET RHEUMATOLOGY, 2024, 6 (01): : e9 - e9
  • [10] The efficacy and safety of reinstitution of tocilizumab in patients with relapsed active rheumatoid arthritis after long-term withdrawal of tocilizumab
    Sagawa, Akira
    [J]. MODERN RHEUMATOLOGY, 2011, 21 (04) : 352 - 358